The use of iPSCs to generate hematopoietic stem/progenitor cells (HSPC) is of considerable therapeutic interest, as allogeneic HSPC transplantation is limited by the lack of compatible donors, high risks of engraftment failure and GVHD. Efficacy and safety assessments are required and non-human primates (NHP) are the most appropriate animal model for preclinical validation. We generated and characterized Macaca cynomolgus iPSCs (cyiPSCs). We assessed their capacity to differentiate in vitro, in the presence of hematopoietic cytokines, and determined the molecular signature triggered during hematopoietic differentiation. We then investigated cy-iPSC-derived hematopoietic cell engraftment in NSG mice, an essential step before the scaling up of hematopoietic cell production for autologous transplantation in monkeys.
Cynomolgus primary cells were refractory to standard reprogramming techniques.
( 1 )
However, we were able to reprogram them efficiently, through two rounds of retroviral transduction, with molecules known to improve iPSC generation (mixture of SB431542, PD0325901, and thiazovivin, or VPA alone),
u s i n g t h e
procedure summarized in Online Supplemental Figure S1 . Cy-iPSCs expressed the pluripotency marker alkaline phosphatase, SSEA4 and the endogenous factors NANOG, REX-1, OCT3/4, SOX2, KLF4 and MYC.
Several iPS clones displayed incomplete silencing of the exogenous genes, although all expressed the DNMT genes involved in the de novo methylation of proviral DNA,
consistent with previous reports for hESCs,
the hematopoietic marker CD45 was not detected before day 10 and its expression level increased over time, reaching 8% by day 21. CD11b myeloid cells were detected on day 10 and accounted for 5% of cells on day 21 (Figure 1A) .
Only a few cells could be retrieved from the supernatant before day 14 and were used for 
described as hemogenic precursors. PU-1 and RUNX-1 were induced on day 8, with expression peaking on day 18. CEBPα expression increased from day 4, peaking on day 21. GATA-1 was induced after day 15, whereas MYB was not expressed in EB cells (Figure 2A ). EB-derived CFU-M and CFU-G activities were correlated with the expression of PU.1, FLi-1 and CEBPα, whereas BFU-E erythroid colonies were correlated with the second wave of SCL, ( Figure 3B ; Online Supplemental Figure   S4 ). We confirmed the presence of monkey cells in mice by quantitative PCR and showed that all femurs containing NHP-CD45 + cells, except one LF, tested positive for the specific probe. NHP-DNA accounted for 0.75% to 11% of total mouse BM DNA ( Figure 3C 
It was suggested that a vascular niche expressing JAG1/DLL4 activated Notch signaling in hemangioblastic cells, upregulating the GATA-2 and RUNX1 genes, mediating endothelial-to-hematopoietic transition and the emergence of definitive HSCs. In our specific cytokine-induced hematopoietic cells, a hemangioblastic population emerged and hematopoietic genes, including GATA-2 and RUNX1, were activated consistent with Gori's model; however, short-term engraftment was weaker as compared to their cytokine-induced strategy and there was no long-term engraftment. In the absence of additional modifications, autologous transplantation will undoubtedly provide the most appropriate niche for evaluating the hematopoietic potential of cy-iPSCs.
Footnotes
Supplemental data are available online including Supplemental methods, Supplemental legends, Supplemental Tables S1, S2, The authors have no potential conflicts of interest to declare. Each bar corresponds to one mouse with no specific order of the mice. 
Derivation of primary cells, retrovirus production and cynomolgus iPSC derivation
Total BM cells were cultured in α-MEM ( The medium was replaced, 24 h later, by standard human ESC medium containing 20% knockout serum (Gibco) and 4 ng/ml FGF2 (Peprotech), as described elsewhere 8 . The medium was then replaced daily, over a period of several weeks. VPA treatment was stopped after seven days, whereas S.P.T levels were maintained in the corresponding wells.
Conditioned medium (CM) was added to the transduced primary cells treated with VPA, to compensate for MEF detachment due to VPA toxicity. CM was collected daily from MEFs incubated for 24 hours in hESC medium. Three to five weeks later, 46 colonies were picked and successfully expanded on MEFs; 31 of these colonies had an indisputable iPSC phenotype (Supplemental Table S2 Table S1 .
Gene methylation profiles and iPSC karyotyping
Two CpG loci in the Macaca NANOG promoter, at positions (-700 to -563) and (-558 to -274) relative to the transcription start site (TSS), and in the OCT3/4 promoter, at positions (-572 to -519) and (-339 to -89) 
Transplantation into NSG mice
The 17-day-old EBs were dissociated and 10 6 unsorted cells were injected into the right femurs of sublethally irradiated NSG mice. Similar numbers of cells were used for retroorbital injections. We injected 10 6 freshly sorted cynomolgus BM CD34 + cells, a population enriched in hematopoietic stem cells, into the right femurs of positive control mice. Mice were sacrified 8 to 10 weeks after transplantation. BM cells retrieved from treated and control femurs were analyzed for hematopoietic cell markers, with specific anti-NHP CD45, CD20, CD11b, CD14 and specific anti-mouse CD45 antibodies.
Detection of non-human primate (NHP) DNA in NSG mice and colony-forming cells
For NHP DNA detection in the BM of NSG mice, we performed real-time PCR with probes specific for the MIGR DNA vector and the mouse actin gene. DNA extracted from cy-iPSC and untreated mouse BM was used to establish standard curves for specific DNA quantification.
Cells retrieved from treated and untreated femurs were plated in methylcellulose H4434
(Stem Cell Technologies) in duplicate, at a density of 1.5 x10 5 cells/well. We picked 100 colonies per sample and extracted genomic DNA with the DNA Extract all Reagent kit (Applied Biosystems). We performed qPCR with specific Macaca p28S and mouse actin TaqMan probes (Supplemental Table S1 ), on an ABI PRISM 7300 (Applied Biosystems).
Figure legends
Supplemental Figure S1 cy-iPSC derivation: Experimental procedure summary for the derivation of iPSCs from 
